FDA Clears Ossio’s Bone Pin Family

January 14, 2019

The FDA granted 510(k) clearance for Ossio’s Ossiofiber bone pin family for use as a non-permanent treatment for treating forefoot conditions in the foot and ankle.

The pins use the company’s intelligent bone regeneration technology, a non-permanent fixation material that is meant to serve as an alternative to permanent fixation implants.

They can be inserted and fixated using existing surgical techniques and fully integrates with the patient’s anatomy in approximately 18 to 24 months.

View today's stories